Kansenshogaku Zasshi
Online ISSN : 1884-569X
Print ISSN : 0387-5911
ISSN-L : 0387-5911
Comparative Test of the Effectiveness of Clindamycin Phosphate and Lincomycin Hydrochloride on Acute Pneumonia (II)
Keiichi NAKAGAWAMasaru KOYAMAKatsuhito ITOTakashi YAMAMOTOMasami UEDAAkira FUKUIAkira SAITOIchiro NAKAYAMAMasumi TOMIZAWAKatsuhiko MATSUIMorikuni ABEKazuo TAKEBEShuichiro YOSHIDAKatsuhiro OKAMOTOEiko TAKAHASHIShiro KOSAKAHitoshi YASHIROYuzuru FUJIOKAMitsuo MASUDAHajime WATANABESeiichi MURAKAMIMasafumi KITAOKAKatsumi ENDOToyokazu TAMURATakeshi OSONOIMasato HAYASHIChiyohiko SHINDOTahei MURAKAMIYasuro SATOIzumi HAYASHIFusanosuke YAMASAKUYasutoshi SUZUKIOsamu SEKINEYoshimaru USUDANobuki AOKIYutaka KANAZAWAMasataka KATSUShinji OKUIMasakatsu HAYAKAWAJunzaburo KABEIppei FUJIMORIYoshio KOBAYASHIYoshihiko TAKEDAKaoru OYAMAHiroshi OKUBOYuruko OKAMOTOYoshihiro UEDAKeigo MAEHARARinzo SOEJIMAYoshihito NIKIHiroo MORIKazuko YAMAZAKIYoshiro SAWAEKeizo MATSUMOTOHiroshi SUZUKIMasashi YAMAMOTOToshiaki YOSHIDAHarumi SHISHIDO
Author information
JOURNAL FREE ACCESS

1982 Volume 56 Issue 5 Pages 403-433

Details
Abstract

The therapeutic effectiveness and side effects of CLDM-P were investigated in a series of double blind studies using LCM as control in the treatment of acute pneumonia. These studies were conducted in 25 institutions throughout the country on 119 cases. Twenty-five (25) out of these cases were excepted from evaluation and 94 cases were evaluated. A dose of 600 mg of the compounds were dissolved in 200-300 ml of aqueous sugar solution or normal saline solution and given by drip infusion over an hour twice a day with a 12 hours interval.
Evaluation was made on 50 patients treated with CLDM-P and 44 with LCM. General improvement was shown in 88.0% of the CLDM-P group and 93.2% of the LCM group; both drugs proved highly effective, with no significant difference between them.
As for symptoms or clinical findings, the CLDM-P group showed significantly better improvement or improving tendency than the other in some evaluation items, probably because CLDM has higher activity than LCM. No significant difference was noted between two treatment groups in the incidences of side effects and abnormal laboratory values. It may be concluded that CLDM-P is effective in treating acute pneumonia.

Content from these authors
© The Japansese Association for Infectious Diseases
Previous article Next article
feedback
Top